B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy for infant leukemia enters phase 2 trial
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can better treat infants with a type of leukemia called acute lymphoblastic leukemia (ALL). About 153 infants up to 1 year old will take part. The goal is to see if these com…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:56 UTC
-
New hope for rare leukemia: drug combo targets Cancer's survival protein
Disease control Recruiting nowThis early-phase study tests whether adding venetoclax (a drug that blocks a protein cancer cells need to survive) to a standard chemotherapy regimen is safe for adults aged 18–54 with a specific, hard-to-treat type of B-cell acute lymphoblastic leukemia (Ph-like ALL). About 24 p…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New combo therapy aims to boost leukemia survival in young adults
Disease control Recruiting nowThis study tests whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy helps young adults (ages 18-39) with newly diagnosed B-cell acute lymphoblastic leukemia. About 310 participants will receive either chemo alone or chemo plus the targeted drug. …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
Experimental CAR T-Cell therapy targets tough blood cancers
Disease control Recruiting nowThis early-phase study tests a new type of CAR T-cell therapy for people with blood cancers like leukemia, lymphoma, or multiple myeloma that have returned or not improved with standard treatments. The therapy uses a patient's own immune cells, modified to target and attack cance…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Could a targeted antibody boost leukemia survival in High-Risk kids?
Disease control Recruiting nowThis large phase 3 study is testing whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy and immunotherapy can improve outcomes for children and young adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). The drug works like a guided m…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Promising combo therapy targets tough leukemia in kids and young adults
Disease control Recruiting nowThis study tests a new way to treat a specific type of leukemia (Ph+ or Ph-like B-ALL) in children and young adults. It combines standard chemotherapy with targeted drugs (dasatinib or imatinib) and an immunotherapy drug (blinatumomab) that helps the immune system attack cancer c…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Promising new combo therapy aims to improve leukemia treatment
Disease control Recruiting nowThis study is for adults newly diagnosed with B-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tests a treatment plan that combines standard chemotherapy (Hyper-CVAD) with two targeted drugs: blinatumomab and inotuzumab ozogamicin. The goal is to see if thi…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Can we safely give fewer blood transfusions to leukemia patients?
Knowledge-focused Recruiting nowThis study looks at whether giving red blood cell transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and maintains quality of life in adults with acute leukemia or related cancers who have had chemotherapy or a stem cell transplant. About 50 partic…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 26, 2026 05:57 UTC